As an important member of the AKR1C family, AKR1C4 expression was found to be elevated in colorectal carcinoma and lung cancer; however, there is no known study illustrating the prognostic value of AKR1C4 in NPC patients [17, 18]. The gene discussed is AKR1C4; the disease is nasopharyngeal carcinoma.